Nuvation Bio (NUVB) EBT Margin Growth (1y) (2025 - 2026)

Nuvation Bio (NUVB) EBT Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -153.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -571.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 452.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1,076.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -9,422.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -392.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1,911.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,565.00
10 Nuvation Bio 2.16 Bn 2.16 Bn 30.78 Mn 102,260.00

Historic Data

Download Data
DateValue
Jun 30, 2026 102,260.00
Mar 31, 2026 173,268.00
Dec 31, 2025 77,838.00
Sep 30, 2025 524,326.00
Jun 30, 2025 3.10 Mn